PHK
NAGE

Point72 Hong Kong’s Niagen Bioscience NAGE Stock Holding History

Point72 Hong Kong’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-400
Closed -$1K – 2490
2022
Q2 		$1K Buy
400
+200
+100% +$391 ﹤0.01% 1832
2022
Q1 		$0 Buy
+200
New +$546 ﹤0.01% 2414
2021
Q2 		– Sell
-2,215
Closed -$21K – 2423
2021
Q1 		$21K Buy
2,215
+2,009
+975% +$15.9K ﹤0.01% 1467
2020
Q4 		$1K Sell
206
-91
-31% -$444 ﹤0.01% 1665
2020
Q3 		$1K Sell
297
-1,538
-84% -$7.42K ﹤0.01% 1145
2020
Q2 		$8K Buy
+1,835
New +$8.21K ﹤0.01% 1008

Other funds holding NAGE

TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
YRHAM
Yong Rong (HK) Asset Management Sheung Wan, Hong Kong $227M AUM 300.38% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Hong Kong's NAGE Position: Q3 2022 in Review

Point72 Hong Kong sold out of Niagen Bioscience (NAGE) in Q3 2022, closing a stake of 400 shares — an estimated $1K sold.

Point72 Hong Kong first reported a position in NAGE in Q2 2020 and held it in 6 quarters. The position peaked at $21K in Q1 2021. 62 funds tracked by Wall St. Rank hold NAGE as of Q3 2022.

  • Point72 Hong Kong reported no remaining Niagen Bioscience position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 400 Niagen Bioscience shares in Q3 2022, an estimated $1K.
  • Point72 Hong Kong first reported a position in Niagen Bioscience in Q2 2020 and held it in 6 quarters.
  • Point72 Hong Kong's Niagen Bioscience position peaked at $21K in Q1 2021.
  • 62 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.